Trilobio, developer of whole lab automation solutions for advancing biology research, today introduced the first version of its comprehensive robotics, lab equipment and software platform at the ...

SPT Labtech, a global leader in the design and development of laboratory automation and liquid handling solutions, and the European Molecular Biology Laboratory's Genomics Core Facility (EMBL GeneCore ...

Presentations in this conference track covered the latest technological advances and methods in microfluidics devices. In the keynote address “Commercialization and Entrepreneurial Lessons from ...

From personalized tutoring to groundbreaking lab automation, AI is reshaping both how we study biology and how scientists make discoveries. Students now have access to interactive AI tutors, visual 3D ...

OpenAI has launched GPT-Rosalind, a large language model fine-tuned for life sciences research, aimed at tasks from genomic analysis to experimental protocol design. The model reportedly leads ...

High-throughput experimentation paired with mass spectrometry (MS) is accelerating drug discovery by enabling rapid, parallel analysis of thousands of chemical reactions and biological assays. While ...

Stay up to date on the latest science with Brush Up Summaries. This Brush Up is sponsored by Bio-Techne. Both semi-automated and fully automated workflows reduce ...

When automation technology first became available for drug discovery, the equipment was expensive and fairly complex to use, and needed a lot of attention and maintenance to stay up-and-running. This ...

“Before COVID, if I said we need to reproduce or scale, people would ask, why?” says Doug Densmore, Co-Founder of Lattice Automation and Asimov. “Now, people get it.” The consequence? An automated ...

The world’s labs are under pressure to do more tests and process more materials, not just due to COVID but from the growing biotech and drug development sectors — and automation is the sure path ...

Forbes contributors publish independent expert analyses and insights. Gary Drenik is a writer covering AI, analytics and innovation. No topic has been discussed more than Covid-19 in the past two ...